Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Ciclosporin
Ikervis
Routinely available
SMC (1089/15)
29/03/2023
Indication
Treatment of severe keratitis in adult patients with dry eye disease, which has not improved despite treatment with tear substitutes.
Therapeutic Area
Eye
Status Description
Routinely available in line with national guidance
Formulation
1mg/mL (0.1%) eye drops emulsion
Comments
-